MarketsandMarkets: In-Vitro Diagnostics BRIC Market Worth $7.3 billion by 2014
04/14/2010

BRIC IVD market is dominated by established players such as Roche, Abbott, Siemens, Beckman Coulter, and Becton Dickinson. However, domestic players such as Transasia, JMitra, Horiba, Kehua, Mindray have taken the distribution of IVD services from urban areas to the rural areas.

Online PR News – 14-April-2010 – – According to a new market research report, ‘In-Vitro Diagnostics (IVD) Market in BRIC (2010 - 2014) ’, published by MarketsandMarkets (www.marketsandmarkets.com), the IVD market in BRIC is expected to be worth US$7.3 billion by 2014, growing at a CAGR of 19% from 2009 to 2014. Market growth is driven mainly by the increasing healthcare budgets of BRIC economies, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases.
Browse in-depth TOC on IVD Market in BRIC (2010 - 2014) market.

Early buyers will receive 10% customization of reports.
http://www.marketsandmarkets.com/Market-Reports/ivd-bric-market-198.html

Despite restraints such as low consumer awareness and the absence of regulations concerning patient safety, the BRIC IVD market is expected to grow from $2.9 billion in 2009 to $7.2 billion-$7.5 billion in 2014 at a CAGR of ~19%-20% from 2009 to 2014. In comparison, the growth rate of the global IVD market is pegged at only ~5%-6% in the next five years. However, the regulations concerning medical devices in these emerging economies still have a long way to go to reach U.S. and European standards. Currently, the BRIC IVD market is dominated by established players such as Roche, Abbott, Siemens, Beckman Coulter, and Becton Dickinson. However, domestic players such as Transasia, JMitra, Horiba, Kehua, Mindray have taken the distribution of IVD services from urban areas to the rural areas.

Scope of the Report

This report categorizes the BRIC IVD market on the basis of:
Geography: Brazil, Russia, India and China
Diagnostic Services: Hematology, immunology, microbiology, molecular diagnostics, urine analysis, etc.
Analyst Briefing Presentation on the In-Vitro Diagnostics (IVD) market in BRIC (2010 - 2014) to be held on 20th April
The Medical Device practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the In-Vitro Diagnostics (IVD) market in BRIC (2010 - 2014) to be held on 20th April The briefing on the IVD Market in BRIC (2010-2014) will benefit the IVD equipment manufacturers, reagent manufacturers, 3rd party distributors of IVD equipment, public and private IVD associations for manufacturers, IVD associations for pathologists, laboratory associations and technology providers.

Table of contents

Executive summary
Market Overview
1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 stakeholders
1.4 RESEARCH methodology & key assumptions
1.5 market segmentation and definitions
2 Summary
3 overview of the global ivd market
3.1 market perspective
4 ivd market overview-brazil
4.1 Market scope
4.2 Market drivers
4.3 market restraints
4.4 trends
4.5 market size
4.6 Competitive landscape
4.7 market forecast
4.8 regulatory body: anvisa
5 ivd market by segments-brazil
5.1 hematology
5.1.1 market size and forecast
5.1.2 competitive landscape
5.2 biochemistry
5.2.1 market size and forecast
5.2.2 competitive landscape
5.3 immunology
5.3.1 market size and forecast
5.3.2 competitive landscape
5.4 molecular diagnostics
5.4.1 market size and forecast
5.4.2 competitive landscape
5.5 microbiology
5.5.1 market size and forecast
5.5.2 competitive landscape
5.6 hemostasis
5.6.1 market size and forecast
5.6.2 competitive landscape
5.7 cytology
5.7.1 market size and forecast
5.7.2 competitive landscape
5.8 cardiac markers
5.8.1 market size and forecast
5.8.2 competitive landscape
5.9 hormones/marking tumors
5.9.1 market size and forecast
5.9.2 competitive landscape
6 ivd market overview- russia
6.1 market scope
6.2 market drivers
6.3 market restraints
6.4 trends
6.5 market size
6.6 competitive landscape
6.7 market forecast
6.8 regulatory body
7 ivd market by segments- russia
7.1 hemotology
7.1.1 market size and forecast
7.1.2 competitive landscape
7.2 biochemistry
7.2.1 market size and forecast
7.2.2 competitive landscape
7.3 immunology
7.3.1 market size and forecast
7.3.2 competitive landscape
7.4 molecular diagnostics
7.4.1 market size and forecast
7.4.2 competitive landscape
7.5 microbiology
7.5.1 market size and forecast
7.5.2 competitive landscape
8 ivd market overview- india
8.1 market scope
8.2 market drivers
8.3 market restraints
8.4 trends
8.5 market size
8.6 competitive landscape
8.7 market forecast
8.8 regulations for diagnostic equipments in India
9 ivd market by segments- india
9.1 hematology
9.1.1 market size and forecast
9.1.2 competitive landscape
9.2 biochemistry
9.2.1 market size and forecast
9.2.2 competitive landscape
9.3 immunology
9.3.1 market size and forecast
9.3.2 competitive landscape
9.4 molecular diagnostics
9.4.1 market size and forecast
9.4.2 competitive landscape
9.5 urinalysis
9.5.1 market size and forecast
9.5.2 competitive landscape
10 ivd market overview- china
10.1 market scope
10.2 market drivers
10.3 market restraints
10.4 trends
10.5 market size
10.6 competitive landscape
10.7 market forecast
10.8 regulation process for medical devices
11 ivd market by segments- china
11.1 hematology
11.1.1 market size and forecast
11.1.2 competitive landscape
11.2 biochemistry
11.2.1 market size and forecast
11.2.2 competitive landscape
11.3 immunology
11.3.1 market size and forecast
11.3.2 competitive landscape
11.4 molecular diagnostics
11.4.1 market size and forecast
11.4.2 competitive landscape
11.5 microbiology
11.5.1 market size and forecast
11.5.2 competitive landscape
12 competitive landscape
12.1 Mergers & AcquisitionS in IVD Market
13 Company Profile
13.1 Abbott Diagnostics
13.2 Beckman Coulter Inc
13.3 Becton, Dickinson & Co.
13.4 BioMérieux SA
13.5 Bio-Rad Laboratories Inc.
13.6 DiaSorin Diagnostics SpA
13.7 Horiba Ltd.
13.8 Mindray Ltd
13.9 Ortho-Clinical Diagnostics Inc
13.1 Oxoid Ltd
13.11 Qiagen N.V
13.12 Roche Diagnostics Ltd
13.13 Siemens Healthcare
13.14 Sysmex Corp

Related Reports

http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market%20-136.html
http://www.marketsandmarkets.com/Market-Reports/home-health-care-market-133.html
http://www.marketsandmarkets.com/Market-Reports/biosimilars-40.html

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
http://www.marketsandmarkets.com